IMAI YOICHI    Department   School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine    Position
Language	Japanese
Title	MLL is a novel target of anti-myeloma therapy and it is degraded by inhibitors of HDAC and HSP90
Conference Type	Nationwide Conferences
Presentation Type	Speech
Lecture Type	General
Date	2012/10/21
Society abstract	臨床血液 53(9),1153 2012